keyword
https://read.qxmd.com/read/38666955/microbiome-sex-related-diversity-in-non-muscle-invasive-urothelial-bladder-cancer
#41
JOURNAL ARTICLE
Konrad Bilski, Natalia Żeber-Lubecka, Maria Kulecka, Michalina Dąbrowska, Aneta Bałabas, Jerzy Ostrowski, Aleksandra Dobruch, Jakub Dobruch
Sex-specific discrepancies in bladder cancer (BCa) are reported, and new studies imply that microbiome may partially explain the diversity. We aim to provide characterization of the bladder microbiome in both sexes diagnosed with non-muscle-invasive BCa with specific insight into cancer grade. In our study, 16S rRNA next-generation sequencing was performed on midstream urine, bladder tumor sample, and healthy-appearing bladder mucosa. Bacterial DNA was isolated using QIAamp Viral RNA Mini Kit. Metagenomic analysis was performed using hypervariable fragments of the 16S rRNA gene on Ion Torrent Personal Genome Machine platform...
April 19, 2024: Current Issues in Molecular Biology
https://read.qxmd.com/read/38666908/telomerase-reverse-transcriptase-promoter-mutation-in-young-patients-with-bladder-tumors
#42
JOURNAL ARTICLE
Sonia Pérez González, Victoria Heredia-Soto, Manuel Girón de Francisco, Elia Pérez-Fernández, Rubén Casans-Francés, Marta Mendiola Sabio, Pilar González-Peramato
The TERT (Telomerase Reverse Transcriptase) gene promoter mutation is one of the most prevalent mutations in urothelial bladder tumors and this mutation is related to bladder tumor progression. Our purpose was to evaluate the presence of this mutation in a population of patients who were first diagnosed at age ≤ 40 years and to examine its relationship with tumor characteristics and progression. A molecular study was performed to detect the two most prevalent mutations in the TERT promoter (C228T and C250T)...
March 23, 2024: Current Issues in Molecular Biology
https://read.qxmd.com/read/38666032/thoracic-intra-and-extramedullary-capillary-hemangioma-with-subacute-clinical-course-a-case-report-and-literature-review
#43
Yumeki Yamamoto, Hiroya Shimauchi-Ohtaki, Fumiaki Honda, Takahiro Shirakura, Keigo Aramaki, Ryosuke Shintoku, Takaaki Miyagishima, Masanori Aihara, Hideaki Yokoo, Yuhei Yoshimoto
Capillary hemangiomas are benign tumors comprising a lobulated proliferation of capillary vessels frequently located in the soft tissues of the neck and head. Spinal intradural capillary hemangiomas are rare, particularly intramedullary lesions. To our knowledge, only 31 cases of spinal intramedullary capillary hemangiomas have been reported. Here, we describe a rare case of a thoracic capillary hemangioma comprising extramedullary and intramedullary components. A 51-year-old male patient presented with bilateral lower extremity numbness and subsequent paraparesis, sensory disturbance, and bladder-bowel dysfunction with a subacute clinical course...
2024: NMC Case Report Journal
https://read.qxmd.com/read/38666027/machine-learning-based-identification-of-a-consensus-immune-derived-gene-signature-to-improve-head-and-neck-squamous-cell-carcinoma-therapy-and-outcome
#44
JOURNAL ARTICLE
Xueying Hu, Haiqun Dong, Wen Qin, Ying Bin, Wenhua Huang, Min Kang, Rensheng Wang
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC), an extremely aggressive tumor, is often associated with poor outcomes. The standard anatomy-based tumor-node-metastasis staging system does not satisfy the requirements for screening treatment-sensitive patients. Thus, an ideal biomarker leading to precise screening and treatment of HNSCC is urgently needed. METHODS: Ten machine learning algorithms-Lasso, Ridge, stepwise Cox, CoxBoost, elastic network (Enet), partial least squares regression for Cox (plsRcox), random survival forest (RSF), generalized boosted regression modelling (GBM), supervised principal components (SuperPC), and survival support vector machine (survival-SVM)-as well as 85 algorithm combinations were applied to construct and identify a consensus immune-derived gene signature (CIDGS)...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38664366/a-potential-strategy-for-bladder-cancer-treatment-inhibiting-autophagy-to-enhance-antitumor-effects-of-nectin-4-mmae
#45
JOURNAL ARTICLE
Yichen Wang, Yanyang Nan, Chunguang Ma, Xiaolin Lu, Qian Wang, Xiting Huang, Wenjing Xue, Jiajun Fan, Dianwen Ju, Dingwei Ye, Xuyao Zhang
Research and development on Nectin-4 antibody-drug conjugates (ADC) have been greatly accelerated since the approval of enfortumab vedotin to treat uroepithelial cancer. During the course of this study, we identified that autophagy serves as a cytoprotective mechanism during Nectin-4-MMAE treatment and proposed a strategy to enhance the antitumor effects of Nectin-4-MMAE in bladder cancer. Nectin-4-MMAE rapidly internalized into bladder cancer cells in 30 minutes and released MMAE, inducing the onset of caspase-mediated apoptosis and leading to the inhibition of tumor cell growth...
April 25, 2024: Cell Death & Disease
https://read.qxmd.com/read/38664180/an-exploratory-study-investigating-the-impact-of-the-bladder-tumor-microbiome-on-bacillus-calmette-guerin-bcg-response-in-non-muscle-invasive-bladder-cancer
#46
JOURNAL ARTICLE
Jacob Knorr, Zaeem Lone, Glenn Werneburg, Ava Adler, Jose Agudelo, Mangesh Suryavanshi, Rebecca A Campbell, Kyle Ericson, Hong Qiu, Petar Bajic, Georges-Pascal Haber, Christopher J Weight, Philip P Ahern, Nima Almassi, Aaron W Miller, Byron H Lee
PURPOSE: Intravesical Bacillus Calmette-Guerin (BCG) is standard of care for intermediate- and high-risk non-muscle invasive bladder cancer (NMIBC). The effect of the bladder microbiome on response to BCG is unclear. We sought to characterize the microbiome of bladder tumors in BCG-responders and non-responders and identify potential mechanisms that drive treatment response. MATERIALS AND METHODS: Patients with archival pre-treatment biopsy samples (2012-2018) were identified retrospectively...
April 24, 2024: Urologic Oncology
https://read.qxmd.com/read/38664179/voided-urine-cytology-is-a-useful-tool-predicting-non-muscle-invasive-bladder-cancer-risk-before-surgery
#47
JOURNAL ARTICLE
Carmen Gómez Del Cañizo, Ignacio González Ginel, Cristina Martín-Arriscado Arroba, Ana de la Calle Moreno, Mario Hernández Arroyo, Alfredo Rodríguez Antolín, Félix Guerrero Ramos
OBJECTIVE: To determine the accuracy of voided urinary cytology (VUC) in predicting of non-muscle-invasive bladder cancer (NMIBC) risk stratification before surgery. METHODS: We prospectively collected data from all patients diagnosed with bladder cancer in our institution over 2 years. We have analyzed VUC accuracy of positive and suspicious VUC in the detection of high-risk tumors and negative and atypical VUC in the detection of low-risk tumors. To test this accuracy, we assessed sensitivity, specificity, positive (PPV) and negative predictive values (NPV), diagnostic odds ratio (DOR), and generated ROC curves (receiver operating characteristic curve)...
April 24, 2024: Urologic Oncology
https://read.qxmd.com/read/38663962/emerging-trends-in-gastrointestinal-cancers-targeting-developmental-pathways-in-carcinogenesis-and-tumor-progression
#48
REVIEW
Afza Ahmad, Rohit Kumar Tiwari, Saleha Siddiqui, Muskan Chadha, Ratnakar Shukla, Vivek Srivastava
Gastrointestinal carcinomas are a group of cancers associated with the digestive system and its accessory organs. The most prevalent cancers related to the gastrointestinal tract are colorectal, gall bladder, gastric, hepatocellular, and esophageal cancers, respectively. Molecular aberrations in different signaling pathways, such as signal transduction systems or developmental pathways are the chief triggering mechanisms in different cancers Though a massive advancement in diagnostic and therapeutic interventions results in improved survival of patients with gastrointestinal cancer; the lower malignancy stages of these carcinomas are comparatively asymptomatic...
2024: International Review of Cell and Molecular Biology
https://read.qxmd.com/read/38663476/brusatol-hinders-the-progression-of-bladder-cancer-by-chac1-nrf2-slc7a11-pathway
#49
JOURNAL ARTICLE
X I Yu, Ziqi He, Qinghua Wang, Shuai Ke, Huaxin Wang, Zhong Wang, Shenglan Li
Bladder cancer is a common tumor that impacts the urinary system and marked by a significant fatality rate and an unfavorable prognosis. Promising antineoplastic properties are exhibited by brusatol, which is obtained from the dried ripe fruit of Brucea javanica. The present study aimed to evaluate the influence of brusatol on the progression of bladder cancer and uncover the molecular mechanism involved. We used Cell Counting Kit-8, colony formation and EdU assays to detect cell numbers, viability and proliferation...
April 24, 2024: Experimental Cell Research
https://read.qxmd.com/read/38663315/the-quantity-function-and-anti-tumor-effect-of-mucosal-associated-invariant-t-cells-in-patients-with-bladder-cancer
#50
JOURNAL ARTICLE
Baodan Zhang, Pengcheng Chen, Jie Zhu, Yongyong Lu
BACKGROUND: Bladder cancer (BC), a prevalent malignancy in the urinary system, often poses challenges for effective treatment. Immunotherapy, harnessing the immune system, has exhibited promise in early-stage clinical trials. Mucosal associated invariant T (MAIT) cells, a subset of immune cells implicated in various diseases, including certain cancer, have yet to be explored in BC patients. We aimed to investigate the quantity, function, and anti-tumor effects of MAIT cells in BC patients...
April 24, 2024: International Immunopharmacology
https://read.qxmd.com/read/38663220/20-hydroxyecdysone-suppresses-bladder-cancer-progression-via-inhibiting-usp21-a-mechanism-associated-with-deubiquitination-and-degradation-of-p65
#51
JOURNAL ARTICLE
Qiang Ma, Fei Wu, Xiaohui Liu, Cuifang Zhao, Yang Sun, Yuanyuan Li, Wei Zhang, Hongge Ju, Yukun Wang
Bladder cancer is one of the most common malignancies of the urinary tract and a prevalent cancer worldwide, still requiring efficient therapeutic agents and approaches. 20-Hydroxyecdysone (20-HE), a steroid hormone, can be found in insects and few plants and mediate numerous biological events to control the progression of varying diseases; however, its impacts on bladder cancer remain unclear. In the study, we found that 20-HE treatments effectively inhibited the viability and proliferation of bladder cancer cells and induced apoptosis by activating Caspase-3...
April 24, 2024: Translational Oncology
https://read.qxmd.com/read/38662237/akr1c2-genetic-variants-mediate-tobacco-carcinogens-metabolism-involving-bladder-cancer-susceptibility
#52
JOURNAL ARTICLE
Yanping Xiao, Yang Shen, Hui Song, Fang Gao, Zhenguang Mao, Qiang Lv, Chao Qin, Lin Yuan, Dongmei Wu, Haiyan Chu, Meilin Wang, Mulong Du, Rui Zheng, Zhengdong Zhang
Tobacco carcinogens metabolism-related genes (TCMGs) could generate reactive metabolites of tobacco carcinogens, which subsequently contributed to multiple diseases. However, the association between genetic variants in TCMGs and bladder cancer susceptibility remains unclear. In this study, we derived TCMGs from metabolic pathways of polycyclic aromatic hydrocarbons and tobacco-specific nitrosamines, and then explored genetic associations between TCMGs and bladder cancer risk in two populations: a Chinese population of 580 cases and 1101 controls, and a European population of 5930 cases and 5468 controls, along with interaction and joint analyses...
April 25, 2024: Archives of Toxicology
https://read.qxmd.com/read/38662077/an-endothelial-related-prognostic-index-for-bladder-cancer-patients
#53
JOURNAL ARTICLE
Deng-Xiong Li, Rui-Cheng Wu, Jie Wang, Qing-Xin Yu, Zhou-Ting Tuo, Lu-Xia Ye, De-Chao Feng, Shi Deng
BACKGROUND: Within the tumor microenvironment, endothelial cells hold substantial sway over bladder cancer (BC) prognosis. Herein, we aim to elucidate the impact of endothelial cells on BC patient outcomes by employing an integration of single-cell and bulk RNA sequencing data. METHODS: All data utilized in this study were procured from online databases. R version 3.6.3 and relevant packages were harnessed for the development and validation of an endothelial-associated prognostic index (EPI)...
April 25, 2024: Discover. Oncology
https://read.qxmd.com/read/38660815/a-transformable-specific-responsive-peptide-for-one-step-synergistic-therapy-of-bladder-cancer
#54
JOURNAL ARTICLE
Zi-Qi Wang, Tian-Rui Qu, Zhi-Shuai Zhang, Fan-Shu Zeng, Hong-Jian Song, Kuo Zhang, Pengyu Guo, Zhichao Tong, Da-Yong Hou, Xiao Liu, Lu Wang, Hao Wang, Wanhai Xu
Synergistic therapy has shown greater advantages compared with monotherapy. However, the complex multiple-administration plan and potential side effects limit its clinical application. A transformable specific-responsive peptide (TSRP) is utilized to one-step achieve synergistic therapy integrating anti-tumor, anti-angiogenesis and immune response. The TSRP is composed of: i) Recognition unit could specifically target and inhibit the biological function of FGFR-1; ii) Transformable unit could self-assembly and trigger nanofibers formation; iii) Reactive unit could specifically cleaved by MMP-2/9 in tumor micro-environment; iv) Immune unit, stimulate the release of immune cells when LTX-315 (Immune-associated oncolytic peptide) exposed...
April 25, 2024: Small
https://read.qxmd.com/read/38660615/rare-case-of-enteric-type-of-urachal-adenocarcinoma-a-case-report
#55
Petar Uchikov, Nedzhat Ali, Krasimir Kraev, Bozhidar Hristov, Atanas Ivanov, Mladen Doykov, Maria Koleva-Ivanova, Angelina Mollova-Kyosebekirova, Maria Kraeva, Dzhevdet Chakarov, Milena Sandeva, Bistra Dobreva-Yatseva, Petar Antonov
Urachal adenocarcinomas, constituting 10 % of bladder adenocarcinomas, pose a significant challenge with limited literature. A 43-year-old male presented with haematuria and abdominal pain, leading to surgical intervention for a 13 cm pelvic tumor. Histopathology identified an intestinal-type primary urachal adenocarcinoma, staged as IIIA, no recurrence on follow-up. Early detection is crucial for improved outcomes in these rare malignancies. While surgery remains the primary treatment, outcomes vary, emphasizing the need for research on standardized protocols...
May 2024: Urology Case Reports
https://read.qxmd.com/read/38659423/perfusion-drugs-for-non%C3%A2-muscle-invasive-bladder-cancer-review
#56
REVIEW
Jingyuan Qian, Qiuchen Zhang, Yang Cao, Xi Chu, Yiyang Gao, Haifei Xu, Hongzhou Cai, Jiajia Wu
The high recurrence rate and poor prognosis of non-muscle invasive bladder cancer (BC) are challenges that need to be urgently addressed. Transurethral cystectomy for bladder tumors is often combined with bladder perfusion therapy, which can effectively reduce the recurrence and progression rates of BC. The present review integrated and analyzed currently available bladder perfusion drugs, mainly including chemotherapeutic agents, immunotherapeutic agents and other adjuvant perfusion drugs. Bacillus Calmette-Guerin (BCG) perfusion was the pioneering immunotherapy for early BC and still ranks high in the selection of perfusion drugs...
June 2024: Oncology Letters
https://read.qxmd.com/read/38658981/otud5-promotes-the-growth-of-hepatocellular-carcinoma-by-deubiquitinating-and-stabilizing-slc38a1
#57
JOURNAL ARTICLE
Yingnan Yang, Siying Jia, Ning Zhu, Xuelian Xiao, Ying Ma, Kangsheng Tu, Yong Guo, Qiuran Xu
BACKGROUND: Deubiquitinating enzymes (DUBs) cleave ubiquitin on substrate molecules to maintain protein stability. DUBs reportedly participate in the tumorigenesis and tumour progression of hepatocellular carcinoma (HCC). OTU deubiquitinase 5 (OTUD5), a DUB family member, has been recognized as a critical regulator in bladder cancer, breast cancer and HCC. However, the expression and biological function of OTUD5 in HCC are still controversial. RESULTS: We determined that the expression of OTUD5 was significantly upregulated in HCC tissues...
April 24, 2024: Biology Direct
https://read.qxmd.com/read/38658905/pd-l1-expression-in-tumor-and-inflammatory-cells-is-associated-with-favorable-tumor-features-and-favorable-prognosis-in-muscle-invasive-urothelial-carcinoma-of-the-bladder-not-treated-by-immune-checkpoint-inhibitors
#58
JOURNAL ARTICLE
Henning Plage, Kira Furlano, Sebastian Hofbauer, Sarah Weinberger, Bernhard Ralla, Antonia Franz, Annika Fendler, Michela de Martino, Florian Roßner, Sefer Elezkurtaj, Martina Kluth, Maximilian Lennartz, Niclas C Blessin, Andreas H Marx, Henrik Samtleben, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Henrik Zecha, Sarah Minner, Ronald Simon, Guido Sauter, Joachim Weischenfeldt, Tobias Klatte, Thorsten Schlomm, David Horst, Simon Schallenberg
BACKGROUND: A high level of PD-L1 expression is the most relevant predictive parameter for response to immune checkpoint inhibitor (CPI) therapy in urinary bladder cancer. Existing data on the relationship between PD-L1 expression and the natural course of disease are controversial and sparse. METHODS: To expand our understanding of the relationship between PD-L1 expression and parameters of cancer aggressiveness, PD-L1 was analyzed on tissue microarrays containing 2710 urothelial bladder carcinomas including 512 patients with follow-up data who underwent radical cystectomy and follow-up therapies in the pre-immune checkpoint inhibitor therapy era...
April 24, 2024: BMC Urology
https://read.qxmd.com/read/38658471/pan-cancer-analysis-shows-that-kifc2-is-a-potential-prognostic-and-immunotherapeutic-biomarker-for-multiple-cancer-types-including-bladder-cancer
#59
JOURNAL ARTICLE
Helin Zhang, Xingxing Zhang, Yuelin Zhang, Dali Han, Hualan Ha, Biao Zhang, Panfeng Shang
KIFC2 plays an important role in prostate cancer progression and chemotherapy resistance, but the mechanism of its involvement in other malignancies remains unclear. Therefore, this study aimed to analyze and validate the mechanism of effect of KIFC2 in multiple tumors. Bioinformatic analysis was performed in conjunction with multiple databases (The Cancer Genome Atlas, Genotype-Tissue Expression Project, Human Protein Atlas, etc.) to fully explore the potential role of KIFC2 within individual tumors and to analyze the correlation with major research components such as prognosis, mutations, and the tumor microenvironment...
April 24, 2024: Molecular Biotechnology
https://read.qxmd.com/read/38658209/high-dose-chemotherapy-with-autologous-stem-cell-transplant-for-patients-with-advanced-germ-cell-tumors-real-world-evidence-from-a-tertiary-cancer-center-in-brazil
#60
JOURNAL ARTICLE
Gabriel Berlingieri Polho, Mateus Trinconi Cunha, Maiana Hamdan Melo Coelho, Jamile Almeida-Silva, Cassio Murilo Hidalgo Filho, Erick Menezes Xavier, Nathalia de Souza Crusoe, Marcelo Junqueira Atanazio, Vitor Fiorin de Vasconcellos, Vivian Naomi Horita, Guilherme Fialho Freitas, David Queiroz Muniz, Vanderson Rocha, Jose Mauricio Mota
BACKGROUND: High-dose chemotherapy followed by stem cell transplant (HDCT) is potentially curative for patients with refractory germ cell tumors (rGCT). There is scarce real-world data supporting its implementation in low- and middle-income countries. We described the experience of our tertiary cancer center in Sao Paulo, Brazil. METHODS: We identified male patients ≥18 years-old with rGCT referred to HDCT after board discussion. Clinical data, including delays in HDCT protocol, were extracted from medical records, and survival outcomes were estimated using the Kaplan-Meier method...
March 24, 2024: Clinical Genitourinary Cancer
keyword
keyword
15410
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.